{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:08:51Z","timestamp":1791446931530,"version":"4.3.3"},"reference-count":144,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T00:00:00Z","timestamp":1467244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Several co-existing diseases and\/or conditions (co-morbidities) are present in patients with heart failure (HF), with diverse clinical relevance. Multiple mechanisms may underlie the co-existence of HF and co-morbidities, including direct causation, associated risk factors, heterogeneity, and independence. The complex inter-relationship of co-morbidities and their impact on the cardiovascular system contribute to the features of HF, both with reduced (HFrEF) and preserved ejection fraction (HFpEF). The purpose of this work is to provide an overview of the contribution of major cardiac and non-cardiac co-morbidities to HF development and outcomes, in the context of both HFpEF and HFrEF. Accordingly, epidemiological evidence linking co-morbidities to HF and the effect of prevalent and incident co-morbidities on HF outcome will be reviewed.<\/jats:p>","DOI":"10.1002\/ejhf.600","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T01:23:06Z","timestamp":1467249786000},"page":"744-758","source":"Crossref","is-referenced-by-count":203,"title":["Reframing the Association and Significance of Co-Morbidities in Heart Failure"],"prefix":"10.1093","volume":"18","author":[{"given":"Filippos","family":"Triposkiadis","sequence":"first","affiliation":[{"name":"Department of Cardiology, Larissa University Hospital , Larissa ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Giamouzis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Larissa University Hospital , Larissa ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Parissis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Athens University Hospital Attikon , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall C.","family":"Starling","sequence":"additional","affiliation":[{"name":"Kaufman Center for Heart Failure, Cleveland Clinic and the Cleveland Clinic Lerner College of Medicine , Cleveland, OH ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harisios","family":"Boudoulas","sequence":"additional","affiliation":[{"name":"The Ohio State University, Columbus, OH, USA; Biomedical Research Foundation Academy of Athens, Athens, and, Aristotelian University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Skoularigis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Larissa University Hospital , Larissa ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[{"name":"Cardiology Division, School of Medicine, Stony Brook University , Stony Brook, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Athens University Hospital Attikon , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"2026011721152675900_ejhf600-bib-0001","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ejhf.30","article-title":"Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey","volume":"16","author":"van Deursen","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0002","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0735-1097(03)00947-1","article-title":"Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure","volume":"42","author":"Braunstein","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0003","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.amjmed.2014.08.024","article-title":"Multimorbidity in heart failure: a community perspective","volume":"128","author":"Chamberlain","year":"2015","journal-title":"Am J Med"},{"key":"2026011721152675900_ejhf600-bib-0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0005","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0195-668X(02)00823-0","article-title":"Part 1: patient characteristics and diagnosis","volume":"24","author":"Cleland","year":"2003","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.amjcard.2014.11.007","article-title":"Relation of left ventricular ejection fraction and clinical features or co- morbidities to outcomes among patients hospitalized for acute heart failure syndromes","volume":"115","author":"Kajimoto","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0007","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.amjcard.2015.07.018","article-title":"Comparison of risk of re- hospitalization, all-cause mortality, and medical care resource utilization in patients with heart failure and preserved versus reduced ejection fraction","volume":"116","author":"Nichols","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/CIRCULATIONAHA.111.080770","article-title":"Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes","volume":"126","author":"Steinberg","year":"2012","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0009","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCA.0b013e328334eb46","article-title":"Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: the Worcester Heart Failure Study","volume":"21","author":"Chinali","year":"2010","journal-title":"Coron Artery Dis"},{"key":"2026011721152675900_ejhf600-bib-0010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0011","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jacc.2005.09.022","article-title":"Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database","volume":"47","author":"Yancy","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0012","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJMoa051530","article-title":"Outcome of heart failure with preserved ejection fraction in a population-based study","volume":"355","author":"Bhatia","year":"2006","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0013","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0014","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.ehj.2004.06.006","article-title":"Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey","volume":"25","author":"Lenzen","year":"2004","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0735-1097(02)02696-7","article-title":"Gender, age, and heart failure with preserved left ventricular systolic function","volume":"41","author":"Masoudi","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction","volume":"37","author":"Solomon","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0017","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"2026011721152675900_ejhf600-bib-0018","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin- converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"key":"2026011721152675900_ejhf600-bib-0019","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"2026011721152675900_ejhf600-bib-0020","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis Investigation Group","year":"1997","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCULATIONAHA.106.628347","article-title":"Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial","volume":"114","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0022","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/eurjhf\/hfr044","article-title":"Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study","volume":"13","author":"von Haehling","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0023","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/eht497","article-title":"Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial","volume":"35","author":"Filippatos","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0024","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gheart.2012.12.006","article-title":"The epidemiology of congestive heart failure: the Framingham Heart Study perspective","volume":"8","author":"Mahmood","year":"2013","journal-title":"Glob Heart"},{"key":"2026011721152675900_ejhf600-bib-0026","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1161\/CIRCHEARTFAILURE.112.968594","article-title":"Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community- based study","volume":"5","author":"Mohammed","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0027","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0028","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1093\/eurheartj\/ehv142","article-title":"Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials","volume":"36","author":"Bavishi","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0029","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.ijcard.2012.11.065","article-title":"Worldwide risk factors for heart failure: a systematic review and pooled analysis","volume":"168","author":"Khatibzadeh","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/eurjhf\/hfs139","article-title":"Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial","volume":"15","author":"Mentz","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0031","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/hrt.2005.066464","article-title":"Coronary artery disease and outcome in acute congestive heart failure","volume":"92","author":"Purek","year":"2006","journal-title":"Heart"},{"key":"2026011721152675900_ejhf600-bib-0032","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0033","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ejhf.221","article-title":"Clinical characteristics and outcomes of patients with angina and heart failure in the CHARM (Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity) Programme","volume":"17","author":"Badar","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0034","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.ehj.2004.03.012","article-title":"Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology","volume":"25","author":"Underwood","year":"2004","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0035","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"key":"2026011721152675900_ejhf600-bib-0036","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.yjmcc.2011.08.028","article-title":"The coronary circulation and blood flow in left ventricular hypertrophy","volume":"52","author":"Camici","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0037","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0038","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jacc.2014.10.070","article-title":"Revascularization in severe left ventricular dysfunction","volume":"65","author":"Velazquez","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0039","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.pcad.2013.01.004","article-title":"Surgical ventricular reconstruction has a role in surgical remodeling in patients with LV systolic dysfunction even post-STICH?","volume":"55","author":"Balsam","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"key":"2026011721152675900_ejhf600-bib-0040","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0041","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0042","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"47","author":"Olsson","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0043","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0044","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0735-1097(97)00254-4","article-title":"Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation","volume":"30","author":"Clark","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0735-1097(96)00592-X","article-title":"Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies","volume":"29","author":"Shinbane","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0046","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.mcna.2012.07.007","article-title":"Atrial fibrillation in heart failure","volume":"96","author":"Lardizabal","year":"2012","journal-title":"Med Clin North Am"},{"key":"2026011721152675900_ejhf600-bib-0047","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/jama.1994.03510350050036","article-title":"Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study","volume":"271","author":"Benjamin","year":"1994","journal-title":"JAMA"},{"key":"2026011721152675900_ejhf600-bib-0048","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.108.821306","article-title":"Atrial fibrillation and heart failure: treatment considerations for a dual epidemic","volume":"119","author":"Anter","year":"2009","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0049","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/cvr\/23.10.882","article-title":"The effect of atrial dilatation on the genesis of atrial arrhythmias","volume":"23","author":"Solti","year":"1989","journal-title":"Cardiovasc Res"},{"key":"2026011721152675900_ejhf600-bib-0050","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1016\/S0140-6736(14)61373-8","article-title":"Efficacy of beta blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis","volume":"384","author":"Kotecha","year":"2014","journal-title":"Lancet"},{"key":"2026011721152675900_ejhf600-bib-0051","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.hrthm.2011.02.014","article-title":"Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis","volume":"8","author":"Wilton","year":"2011","journal-title":"Heart Rhythm"},{"key":"2026011721152675900_ejhf600-bib-0052","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ejhf.346","article-title":"Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis","volume":"17","author":"Simpson","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0053","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0054","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/eurjhf\/hfs016","article-title":"Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study","volume":"14","author":"Agarwal","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0056","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.amjcard.2007.08.046","article-title":"Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure","volume":"101","author":"Rusinaru","year":"2008","journal-title":"Am J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0057","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2013.10.068","article-title":"Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study","volume":"170","author":"Tavazzi","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0058","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJMoa0808836","article-title":"Percent emphysema, airflow obstruction, and impaired left ventricular filling","volume":"362","author":"Barr","year":"2010","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0059","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.echo.2005.01.016","article-title":"Impact of chronic obstructive pulmonary disease with pulmonary hypertension on both left ventricular systolic and diastolic performance","volume":"18","author":"Yilmaz","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"2026011721152675900_ejhf600-bib-0060","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jacc.2013.04.091","article-title":"Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension","volume":"62","author":"Hilde","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0061","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0062","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/eurjhf\/hfn013","article-title":"Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology","volume":"11","author":"Hawkins","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0063","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/ejhf.183","article-title":"Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment","volume":"16","author":"Guder","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0064","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006171","article-title":"Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study","volume":"4","author":"Mullerova","year":"2014","journal-title":"BMJ Open"},{"key":"2026011721152675900_ejhf600-bib-0065","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta-agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0066","article-title":"Indacaterol, a once-daily beta2-agonist, versus twice-daily beta(2)-agonists or placebo for chronic obstructive pulmonary disease","volume":"1","author":"Geake","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2026011721152675900_ejhf600-bib-0067","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMp1008502","article-title":"The safety of tiotropium\u2014the FDA\u2019s conclusions","volume":"363","author":"Michele","year":"2010","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0068","year":"2015"},{"key":"2026011721152675900_ejhf600-bib-0069","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0002-9343(91)90075-9","article-title":"A prospective evaluation of elevated serum theophylline concentrations to determine if high concentrations are predictable","volume":"91","author":"Greenberger","year":"1991","journal-title":"Am J Med"},{"key":"2026011721152675900_ejhf600-bib-0070","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-2332","article-title":"Cardiovascular safety in patients receiving roflumilast for the treatment of COPD","volume":"144","author":"White","year":"2013","journal-title":"Chest"},{"key":"2026011721152675900_ejhf600-bib-0071","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"187","author":"Vestbo","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026011721152675900_ejhf600-bib-0072","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences","volume":"16","author":"Klip","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0073","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.amjcard.2006.01.107","article-title":"Anemia, renal dysfunction, and their interaction in patients with chronic heart failure","volume":"98","author":"de Silva","year":"2006","journal-title":"Am J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0074","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0075","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cardfail.2004.06.435","article-title":"Anemia and new-onset congestive heart failure in the general Medicare population","volume":"11","author":"Sandgren","year":"2005","journal-title":"J Card Fail"},{"key":"2026011721152675900_ejhf600-bib-0076","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ahj.2014.09.010","article-title":"Hemoglobin levels and new-onset heart failure in the community","volume":"169","author":"Klip","year":"2015","journal-title":"Am Heart J"},{"key":"2026011721152675900_ejhf600-bib-0077","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0078","doi-asserted-by":"crossref","DOI":"10.1093\/qjmed\/hcv087","article-title":"Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: results from the MAGGIC individual patient data meta-analysis","volume-title":"QJM","author":"Berry","year":"2016"},{"key":"2026011721152675900_ejhf600-bib-0079","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/ejhf.161","article-title":"Iron deficiency in a multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis","volume":"16","author":"Yeo","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0080","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2015.11.178","article-title":"The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure","volume":"205","author":"Ebner","year":"2015","journal-title":"Int J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0081","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure","volume":"110","author":"Anand","year":"2004","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0082","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2007.07.094","article-title":"Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure","volume":"51","author":"Tang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0083","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2004.10.038","article-title":"Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction","volume":"45","author":"Ishani","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0084","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.104.512988","article-title":"Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0085","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/eurheartj\/ehl012","article-title":"The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET","volume":"27","author":"Komajda","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0086","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0087","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencydagger","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0088","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0089","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0090","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2337\/diacare.26.8.2433","article-title":"Heart failure: the frequent, forgotten, and often fatal complication of diabetes","volume":"26","author":"Bell","year":"2003","journal-title":"Diabetes Care"},{"key":"2026011721152675900_ejhf600-bib-0091","doi-asserted-by":"crossref","first-page":"1727a","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovic","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0092","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"2026011721152675900_ejhf600-bib-0093","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s00125-012-2579-0","article-title":"High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes","volume":"55","author":"Boonman-de Winter","year":"2012","journal-title":"Diabetologia"},{"key":"2026011721152675900_ejhf600-bib-0094","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jchf.2014.08.004","article-title":"Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure","volume":"3","author":"Dei Cas","year":"2015","journal-title":"JACC Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0095","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/eurjhf\/hfq160","article-title":"Heart failure severity, as determined by loop diuretic dosages, predicts the risk of developing diabetes after myocardial infarction: a nationwide cohort study","volume":"12","author":"Andersson","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0096","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00125-010-1965-8","article-title":"Cardiovascular disease, heart failure, chronic kidney disease and depression independently increase the risk of incident diabetes","volume":"54","author":"Nichols","year":"2011","journal-title":"Diabetologia"},{"key":"2026011721152675900_ejhf600-bib-0097","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/diacare.28.1.20","article-title":"Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting","volume":"28","author":"Maru","year":"2005","journal-title":"Diabetes Care"},{"key":"2026011721152675900_ejhf600-bib-0098","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0099","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0100","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCHEARTFAILURE.114.000346","article-title":"GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study","volume":"7","author":"Margulies","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0102","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1681\/ASN.2006101159","article-title":"Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study","volume":"18","author":"Kottgen","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"2026011721152675900_ejhf600-bib-0103","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1681\/ASN.2012020145","article-title":"Associations between kidney function and subclinical cardiac abnormalities in CKD","volume":"23","author":"Park","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2026011721152675900_ejhf600-bib-0104","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ahj.2007.01.028","article-title":"Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease","volume":"153","author":"Rakhit","year":"2007","journal-title":"Am Heart J"},{"key":"2026011721152675900_ejhf600-bib-0105","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1093\/eurheartj\/ehu254","article-title":"Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction","volume":"35","author":"Gori","year":"2014","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0106","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jcmg.2013.09.025","article-title":"Defining the natural history of uremic cardiomyopathy in chronic kidney disease: the role of cardiovascular magnetic resonance","volume":"7","author":"Edwards","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026011721152675900_ejhf600-bib-0107","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","article-title":"Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis","volume":"27","author":"de Silva","year":"2006","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0108","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-012-9306-2","article-title":"Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis","volume":"17","author":"Cleland","year":"2012","journal-title":"Heart Fail Rev"},{"key":"2026011721152675900_ejhf600-bib-0109","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0110","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/eurjhf\/hft089","article-title":"Interaction between baseline and early worsening of renal function and efficacy of renin\u2013angiotensin\u2013aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study","volume":"15","author":"Lesogor","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0111","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jacc.2012.07.048","article-title":"Influence of baseline and worsening renal function on efficacy of spironolactone in patients with severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)","volume":"60","author":"Vardeny","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0112","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCHEARTFAILURE.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0113","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchf.2015.09.014","article-title":"Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF Registry","volume":"4","author":"Arzt","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0114","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.109.901801","article-title":"Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study","volume":"122","author":"Gottlieb","year":"2010","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1164\/rccm.201503-0536OC","article-title":"Redline S; Osteoporotic Fractures in Men Study Research Group. Sleep-disordered breathing and incident heart failure in older men","volume":"193","author":"Javaheri","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2026011721152675900_ejhf600-bib-0116","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/eurjhf\/hfq183","article-title":"Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study","volume":"13","author":"Jilek","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0117","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/eurheartj\/ehu522","article-title":"Sleep disordered breathing and post-discharge mortality in patients with acute heart failure","volume":"36","author":"Khayat","year":"2015","journal-title":"Eur Heart J"},{"key":"2026011721152675900_ejhf600-bib-0118","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.0000061757.12581.15","article-title":"Sleep apnea and heart failure: Part I: obstructive sleep apnea","volume":"107","author":"Bradley","year":"2003","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0119","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.0000061758.05044.64","article-title":"Sleep apnea and heart failure: Part II: central sleep apnea","volume":"107","author":"Bradley","year":"2003","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0120","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/CIRCULATIONAHA.111.070813","article-title":"Sleep apnea and cardiovascular disease: a bidirectional relationship","volume":"126","author":"Kasai","year":"2012","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0121","first-page":"898","article-title":"Heart failure and sleep apnea","volume":"31","author":"Lyons","year":"2015","journal-title":"Can J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0122","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","article-title":"Continuous positive airway pressure for central sleep apnea and heart failure","volume":"353","author":"Bradley","year":"2005","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0123","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/eurjhf\/hft051","article-title":"Rationale and design of the SERVE-HF study: treatment of sleep-disordered breathing with predominant central sleep apnoea with adaptive servo-ventilation in patients with chronic heart failure","volume":"15","author":"Cowie","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0124","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1378\/chest.15-1536","article-title":"A paradigm shift in the treatment of central sleep apnea in heart failure","volume":"148","author":"Mehra","year":"2015","journal-title":"Chest"},{"key":"2026011721152675900_ejhf600-bib-0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N Engl J Med"},{"key":"2026011721152675900_ejhf600-bib-0126","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/CIRCULATIONAHA.108.807289","article-title":"Body mass index and vigorous physical activity and the risk of heart failure among men","volume":"119","author":"Kenchaiah","year":"2009","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0127","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0735-1097(01)01448-6","article-title":"The relationship between obesity and mortality in patients with heart failure","volume":"38","author":"Horwich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0128","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ijo.2013.203","article-title":"The obesity paradox in heart failure patients with preserved versus reduced ejection fraction: a meta-analysis of individual patient data","volume":"38","author":"Padwal","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"2026011721152675900_ejhf600-bib-0129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure","volume":"1","author":"Lavie","year":"2013","journal-title":"JACC Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.trsl.2014.04.010","article-title":"Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management","volume":"164","author":"Alpert","year":"2014","journal-title":"Transl Res"},{"key":"2026011721152675900_ejhf600-bib-0131","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/CIRCIMAGING.111.964627","article-title":"Cardiac remodeling in obesity","volume":"6","author":"Aurigemma","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026011721152675900_ejhf600-bib-0132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0029665115002438","article-title":"The wasting continuum in heart failure: from sarcopenia to cachexia","volume":"74","author":"von Haehling","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"2026011721152675900_ejhf600-bib-0133","first-page":"195","article-title":"Obesity and the obesity paradox in heart failure","volume":"31","author":"Gupta","year":"2015","journal-title":"Can J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0134","first-page":"803","article-title":"Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0135","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"2026011721152675900_ejhf600-bib-0136","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","article-title":"Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes","volume":"48","author":"Rutledge","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0137","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ejhf.133","article-title":"Symptoms of anxiety and depression and risk of heart failure: the HUNT Study","volume":"16","author":"Gustad","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0138","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.161.15.1849","article-title":"Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure","volume":"161","author":"Jiang","year":"2001","journal-title":"Arch Intern Med"},{"key":"2026011721152675900_ejhf600-bib-0139","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.hfc.2013.10.004","article-title":"Heart failure and depression","volume":"10","author":"Newhouse","year":"2014","journal-title":"Heart Fail Clin"},{"key":"2026011721152675900_ejhf600-bib-0140","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1532-5415.2010.02921.x","article-title":"Heart failure and incident late-life depression","volume":"58","author":"Luijendijk","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"2026011721152675900_ejhf600-bib-0141","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijcard.2012.01.062","article-title":"Incidence rates and predictors of major and minor depression in patients with heart failure","volume":"167","author":"Lossnitzer","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0142","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.amjcard.2010.10.013","article-title":"Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study)","volume":"107","author":"Jiang","year":"2011","journal-title":"Am J Cardiol"},{"key":"2026011721152675900_ejhf600-bib-0143","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/CIRCHEARTFAILURE.109.851246","article-title":"Prognosis in heart failure and the value of \u03b2-blockers are altered by the use of antidepressants and depend on the type of antidepressants used","volume":"2","author":"Fosbol","year":"2009","journal-title":"Circ Heart Fail"},{"key":"2026011721152675900_ejhf600-bib-0144","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2010.03.068","article-title":"Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial","volume":"56","author":"O\u2019Connor","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.600","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/7\/744\/66382796\/eurjhf_18_7_744.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/18\/7\/744\/66382796\/eurjhf_18_7_744.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:16:16Z","timestamp":1768702576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/18\/7\/744\/8423290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":144,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,6,30]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.600","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7]]},"published":{"date-parts":[[2016,6,30]]}}}